For the quarter ending 2025-09-30, HSTM had $1,442K increase in cash & cash equivalents over the period. $17,921K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 6,087 | 9,721 |
| Depreciation and amortization | 10,820 | 21,621 |
| Stock-based compensation | 794 | 1,940 |
| Amortization of deferred commissions | 3,173 | 6,017 |
| Provision for credit losses | 177 | 391 |
| Deferred income taxes | 4,588 | 467 |
| Loss on equity method investments | -43 | -107 |
| Other | 370 | 776 |
| Accounts and unbilled receivables | 2,432 | -3,465 |
| Prepaid and other current assets | -1,548 | 1,728 |
| Other assets | 3,285 | 8,596 |
| Accounts payable and accrued expenses | -1,334 | -3,858 |
| Accrued royalties | 819 | -366 |
| Deferred revenue | -2,598 | 3,692 |
| Net cash provided by operating activities | 18,030 | 32,097 |
| Proceeds from maturities of marketable securities | 15,213 | 26,073 |
| Purchases of marketable securities | 15,334 | 26,100 |
| Proceeds from sale of non-marketable equity investments | 0 | 0 |
| Purchase of other investments | 1,000 | 500 |
| Payments associated with capitalized software development | 7,410 | 14,500 |
| Purchases of property and equipment | 109 | 3,372 |
| Net cash used in investing activities | -8,640 | -18,399 |
| Taxes paid related to net settlement of equity awards | 121 | 1,075 |
| Payment of cash dividends | 919 | 1,890 |
| Repurchases of common stock | 6,897 | 18,121 |
| Net cash used in financing activities | -7,937 | -21,086 |
| Effect of exchange rate changes on cash and cash equivalents | -11 | 21 |
| Net (decrease) increase in cash and cash equivalents | 1,442 | -7,367 |
| Cash and cash equivalents at beginning of period | 59,469 | - |
| Cash and cash equivalents at end of period | 53,544 | - |
HEALTHSTREAM INC (HSTM)
HEALTHSTREAM INC (HSTM)